Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Amortization of Deferred Charges (2024 - 2025)

Historic Amortization of Deferred Charges for BioLineRx (BLRX) over the last 2 years, with Q1 2025 value amounting to $702000.0.

  • BioLineRx's Amortization of Deferred Charges changed N/A to $702000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $729000.0, marking a year-over-year change of. This contributed to the annual value of $669000.0 for FY2024, which is N/A changed from last year.
  • As of Q1 2025, BioLineRx's Amortization of Deferred Charges stood at $702000.0.
  • BioLineRx's 5-year Amortization of Deferred Charges high stood at $702000.0 for Q1 2025, and its period low was $27000.0 during Q4 2024.